NeutriSci International Inc. (NRXCF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0013 (-99.92%)
At close: Aug 15, 2024
-99.99%
Market Cap 651.26K
Revenue (ttm) 44.34K
Net Income (ttm) -408.39K
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,200
Average Volume 15,243
Open 0.0000
Previous Close 0.0013
Day's Range 0.0000 - 0.0000
52-Week Range 0.0013 - 0.0013
Beta 0.67
RSI 39.01
Earnings Date May 1, 2025

About NeutriSci International

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. [Read more]

Sector Healthcare
Founded 2009
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol NRXCF
Full Company Profile

Financial Performance

In 2022, NeutriSci International's revenue was 457,750, an increase of 465.86% compared to the previous year's 80,894. Losses were -770,694, -50.98% less than in 2021.

Financial numbers in CAD Financial Statements

News

NeutriSci Announces Successful Completion of R&D in Preparation for Launch of Its Functional Mushroom Product Line

VANCOUVER, BC / ACCESSWIRE / November 30, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for t...

3 years ago - Accesswire

NeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution Partner

VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing product...

3 years ago - Accesswire

NeutriSci Arranges Strategic Financing with Tabletz and Exercise of Warrants

VANCOUVER, BC / ACCESSWIRE / September 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, lic...

3 years ago - Accesswire

Neutrisci Provides Update on Tabletz Developments

VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products,...

4 years ago - Accesswire

Neutrisci Provides Update on Tabletz and Previously Announced Project Development

VANCOUVER, BC / ACCESSWIRE / July 7, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, li...

4 years ago - Accesswire

NeutriSci Provides Update On Biople Product Launch In Japan

VANCOUVER, BC / ACCESSWIRE / June 23, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU) (OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products fo...

4 years ago - Accesswire

Neutrisci Ships Tabletz Rush Order to #1 CBD Retailer in Japan

VANCOUVER, BC / ACCESSWIRE / June 9, 2021 / NeutriSci International Inc. ('NeutriSci' or the 'Company') (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products, licensing...

4 years ago - Accesswire

NeutriSci Completes R&D and Expands Product Selection to Include Beverages

VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT: 1N9), an innovative technology company developing products, l...

4 years ago - Accesswire

NeutriSci and Pacwest Announce Technology and IP Arrangement for R&D Product Development

VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, licencing...

4 years ago - Accesswire

Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product

VANCOUVER, BC / ACCESSWIRE / May 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products ...

4 years ago - Accesswire

Neutrisci Receives Additional Order for Japanese Market

VANCOUVER, BC / ACCESSWIRE / May 3, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for the nut...

4 years ago - Accesswire

Neutrisci Announces New State-Of-The-Art Production and Research Facility in Las Vegas, Nevada, USA

VANCOUVER, BC / ACCESSWIRE / March 18, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products f...

4 years ago - Accesswire

NeutriSci: Harmonized Code Approval Received by TABLETZ LLC., in Japan

VANCOUVER, BC / ACCESSWIRE / March 8, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products for the n...

4 years ago - Accesswire

NeutriSci Receives Multi Million Dollar Order for Japanese Market

long-term growth strategy for second-largest medical cannabis market in Asia we anticipate further orders based upon our initial market interest VANCOUVER, BC / ACCESSWIRE / January 18, 2021 / NeutriS...

4 years ago - Accesswire